Loading
Total declarations
Company
▲ Purchases (12 ops.)
▼ Sales (0 ops.)
Latest filing published 29 May 2026 for Edesa Biotech, Inc..
Filing timeline
BuySaleMichael J. Brooks
Insider track record
Disclosed buys
12
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-21.9%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Michael J. Brooks: trading record in brief
Michael J. Brooks is a declared insider of Edesa Biotech, Inc. (chief executive), with filings sourced from SEC (Form 4). The record holds 18 filings, for trades running from 8 January 2020 to 27 May 2026.
Every open-market trade on record is a purchase: 12 purchases worth €75k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 6 share grants. Since January 2026: 1 purchase and no sales on the market.
In size, the median ticket on the buying side is €4,188. Clusters matter here: 10 out of 12 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The newest entry dates from 29 May 2026: a share grant, in Edesa Biotech, Inc. The most recent open-market purchase was published on 11 March 2026, 227 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael J. Brooks
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
64,609 shares0Common SharesSEC:0001171843-26-003801:0
2,000 shares@ US$1.578.4% of flowCommon SharesSEC:0001171843-26-001490:0
Canonical exit: 27 May 2026 (T+90)
207,201 shares0Common SharesSEC:0001171843-25-003587:0
93,200 sharesCommon SharesSEC:0001654954-23-010167:0
4,239 shares@ US$1.12516.8% of flowCommon SharesSEC:0001654954-22-014747:0
3,000 shares@ US$1.49430.0090% mcap17.9% of flowCommon SharesSEC:0001654954-22-009005:0
Canonical exit: 27 Sept 2022 (T+90)
3,000 shares@ US$1.60550.0096% mcap19.0% of flowCommon SharesSEC:0001654954-22-008536:0
Canonical exit: 14 Sept 2022 (T+90)
3,500 shares@ US$1.7418.1% of flowCommon SharesSEC:0001654954-22-007559:0
Canonical exit: 23 Aug 2022 (T+90)
1,250 shares@ US$2.789310.1% of flowCommon SharesSEC:0001654954-22-003144:0
Canonical exit: 12 Jun 2022 (T+90)
1,000 shares@ US$3.22299.2% of flowCommon SharesSEC:0001654954-22-002936:0
Canonical exit: 8 Jun 2022 (T+90)
1,250 shares@ US$2.897510.6% of flowCommon SharesSEC:0001654954-22-002765:0
Canonical exit: 6 Jun 2022 (T+90)
11 of 11 declarations
